Keros Therapeutics Inc. (KROS) Social Stream



Keros Therapeutics Inc. (KROS): $50.43

1.94 (-3.70%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add KROS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#294 of 360

in industry

KEROS THERAPEUTICS INC (KROS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering KEROS THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-10 3 $100 $75 $86.25 $48.19 78.98%
2022-05-09 4 $100 $75 $86.25 $48.19 78.98%
2022-06-10 4 $120 $75 $93.75 $48.19 94.54%
2022-08-05 5 $120 $75 $91 $48.19 88.84%
2022-09-13 5 $120 $75 $94 $48.19 95.06%
2022-11-07 6 $120 $75 $95 $48.19 97.14%
2023-02-08 6 $120 $75 $96.666 $48.19 100.59%
2023-03-08 7 $120 $75 $96.666 $48.19 100.59%
2023-05-25 7 $110 $75 $95 $48.19 97.14%
2023-07-26 8 $110 $65 $90.714 $48.19 88.24%
2023-08-08 9 $110 $65 $90.125 $48.19 87.02%
2023-11-07 9 $110 $66 $90.25 $48.19 87.28%
2023-11-13 9 $105 $60 $85.285 $48.19 76.98%
2023-12-08 10 $105 $60 $82.125 $48.19 70.42%

The Trend in the Analyst Price Target


Over the past 18 months, KROS's average price target has gone down $11.62.

Over the past 43 weeks, KROS's average upside potential has been 136.69%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-25 7 110 75 95.000 50.25 89.05%
2023-08-07 9 110 65 90.125 40.42 122.97%
2023-11-06 9 110 66 90.250 31.69 184.79%
2023-11-13 9 105 60 87.750 29.99 192.6%
2023-12-08 10 105 60 82.125 35.65 130.36%

KROS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 10 0 0 0 0 10

The Trend in the Broker Recommendations


KROS's average broker recommendation rating improved by 0 over the prior 14 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KROS as an investment opportunity.

  • In the context of all US stocks, KEROS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1398.67% of them.
  • In the context of stocks in the small market cap category, KEROS THERAPEUTICS INC's average analyst price target is higher than 1765.67% of them.
  • KEROS THERAPEUTICS INC's number of analysts covering the stock is higher than 1330.73% of stocks in the small market cap category.
  • KROS has a lower variance in analysts' estimates than -440.09% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KEROS THERAPEUTICS INC are ARQT, RAPT, and TFFP.

Is KROS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!